Commercialized a highly effective skin cancer scanning device
Used for over 12 years and supported by more than 15 published clinical studies
MedX Health Corporation Links
Beacon Securities Research Report - June 24, 2020
Please visit https://beaconsecurities.ca for regulatory disclosures.
Posted by:
agoracom administrator
on
Jun 24, 2020 11:34AM
Beacon Securities Research Report
Please visit https://beaconsecurities.ca for regulatory disclosures.
Posted by:
agoracom administrator
on
Jun 17, 2020 01:06PM
Research in Social and Administrative Pharmacy
Dermatological cancer screening: Evaluation of a new community pharmacy service
Posted by:
agoracom administrator
on
Jun 05, 2020 11:03AM